Articles from Algen Biotechnologies
Algen Biotechnologies, a precision therapeutics company pioneering the use of advanced CRISPR and AI to close the gap between promising biology and real patient outcomes, today announced its inclusion on TIME’s annual Best Inventions of 2026 list in the Experimental category.
By Algen Biotechnologies · Via Business Wire · October 15, 2026
Algen Biotechnologies, a precision therapeutics company pioneering the use of advanced CRISPR and AI to close the gap between promising experimental data and real patient outcomes, today announced it has been named to Fast Company's Next Big Things in Tech, an annual list recognizing breakthrough technologies with the potential to transform industries and shape the future.
By Algen Biotechnologies · Via Business Wire · October 6, 2026
Algen Biotechnologies, a biotechnology company pioneering next-generation therapies using advanced CRISPR gene modulation and AI-driven drug discovery, today announced a multi-target partnership with AstraZeneca to accelerate the discovery of novel therapeutic targets in immunology.
By Algen Biotechnologies · Via Business Wire · October 6, 2025